These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Replication characteristics of swine influenza viruses in precision-cut lung slices reflect the virulence properties of the viruses. Meng F; Punyadarsaniya D; Uhlenbruck S; Hennig-Pauka I; Schwegmann-Wessels C; Ren X; Dürrwald R; Herrler G Vet Res; 2013 Nov; 44(1):110. PubMed ID: 24225030 [TBL] [Abstract][Full Text] [Related]
24. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses. Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159 [TBL] [Abstract][Full Text] [Related]
25. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs. Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101 [TBL] [Abstract][Full Text] [Related]
26. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188 [TBL] [Abstract][Full Text] [Related]
27. Comparative pathology of pigs infected with Korean H1N1, H1N2, or H3N2 swine influenza A viruses. Lyoo KS; Kim JK; Jung K; Kang BK; Song D Virol J; 2014 Sep; 11():170. PubMed ID: 25253051 [TBL] [Abstract][Full Text] [Related]
28. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Wesley RD; Tang M; Lager KM Vaccine; 2004 Sep; 22(25-26):3427-34. PubMed ID: 15308368 [TBL] [Abstract][Full Text] [Related]
29. Detection and subtyping of swine influenza H1N1, H1N2 and H3N2 viruses in clinical samples using two multiplex RT-PCR assays. Choi YK; Goyal SM; Kang SW; Farnham MW; Joo HS J Virol Methods; 2002 Apr; 102(1-2):53-9. PubMed ID: 11879692 [TBL] [Abstract][Full Text] [Related]
30. A Bivalent Live Attenuated Influenza Virus Vaccine Protects against Drifted H1N2 and H3N2 Clinical Isolates in Swine. Aubrey L; Barron-Castillo U; Detmer S; Zhou Y Viruses; 2022 Dec; 15(1):. PubMed ID: 36680086 [TBL] [Abstract][Full Text] [Related]
31. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus. Wesley RD; Lager KM Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702 [TBL] [Abstract][Full Text] [Related]
32. Novel reassortant of swine influenza H1N2 virus in Germany. Zell R; Motzke S; Krumbholz A; Wutzler P; Herwig V; Dürrwald R J Gen Virol; 2008 Jan; 89(Pt 1):271-276. PubMed ID: 18089751 [TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines. Loeffen WL; Stockhofe N; Weesendorp E; van Zoelen-Bos D; Heutink R; Quak S; Goovaerts D; Heldens JG; Maas R; Moormann RJ; Koch G Vet Microbiol; 2011 Sep; 152(3-4):304-14. PubMed ID: 21664078 [TBL] [Abstract][Full Text] [Related]
35. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs. Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090 [TBL] [Abstract][Full Text] [Related]
36. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Gauger PC; Vincent AL; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA Vaccine; 2011 Mar; 29(15):2712-9. PubMed ID: 21310191 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of Heterologous Prime-Boost Vaccination with H3N2 Influenza Viruses in Pre-Immune Individuals: Studies in the Pig Model. Chepkwony S; Parys A; Vandoorn E; Chiers K; Van Reeth K Viruses; 2020 Sep; 12(9):. PubMed ID: 32882956 [TBL] [Abstract][Full Text] [Related]
38. Performance of a commercial Swine influenza virus H1N1 and H3N2 antibody enzyme-linked immunosorbent assay in pigs experimentally infected with European influenza viruses. Barbé F; Labarque G; Pensaert M; Van Reeth K J Vet Diagn Invest; 2009 Jan; 21(1):88-96. PubMed ID: 19139506 [TBL] [Abstract][Full Text] [Related]
39. Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection. Pyo HM; Zhou Y Vaccine; 2014 Jun; 32(30):3835-42. PubMed ID: 24837774 [TBL] [Abstract][Full Text] [Related]
40. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus. Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]